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Charge and size of mesangial IgA in IgA nephropathy. To characterize
the physicochemical properties of the mesangial IgA in primary IgA
nephropathy, acid-eluates from percutaneous renal biopsies of 20
patients were examined. The acid-eluates were obtained from 1287
498 glomerular sections. The IgA content (mean 15 10 ng) repre-
sented 0.4% of the total eluted proteins. To analyze the molecular
weight and the charge of eluted IgA, II eluates were subjected to high
pressure liquid chromatography (at pH 6.8 and/or pH 3.5) and five
eluates to isoelectric focusing on agarose. IgA was detected in the
fractions by an IgA-RIA. Comparison of the elution profiles at different
pH showed a statistically significant decrease of the excluded IgA peak
( 1,000,000 daltons), and a significant increase of polymeric IgA peaks
(1,000,000—320,000 and 320,000 daltons) in acidic chromatography, as
compared to non-dissociating conditions. Under acidic conditions,
polymeric IgA represent 64% of total eluted IgA. Secretory component
binding to polymeric IgA was demonstrated in four out of eight eluates
tested. The isoelectric point (p1) of etuted IgA ranged from 4.5 to 5.6,
contrasting with the broader and more neutral p1 of normal serum lgA
(4.5 to 6.8). This study shows that the multimeric nature of lgA, the
formation of IgA complexes, and the anionic charge of IgA are likely to
be involved in the mesangial IgA deposition in idiopathic IgA
nephropathy.
Charge et poids moleculaire des IgA mésangiales au cours de Ia
néphropathie a IgA. Les caractéristiques physico-chimiques des IgA
mésangiales éluées a partir de biopsies rénales percutanées chez 20
malades atteints de Ia néphropathie a IgA ont été étudiées. Les eluats
acides ont été obtenus a partir de 1287 498 sections de glomérules. La
moyenne de Ia quantité d'lgA éluées (15 10 ng) représente 0,4% du
total de protéines éluées. Dc facon a préciser le poids moléculaire et Ia
charge des IgA éluées, 11 éluats ont été analyses aprés chromatographie
liquide a haute pression (a pH 6.8 et/ou a pH 3.5) et cinq eluats ont CtC
analyses par isoClectrofocalisation en agarose. Les IgA ont etC dCtectCs
dans les fractions chromatographiques ou Clectrophoretiques par RIA-
IgA. La comparaison des profils d'élution obtenus a pH acide et a pH
neutre a montrC une diminution significative des IgA prCsentes dans Ic
pic d'exclusion ( 1,000,000 daltons) et une augmentation significative
du pic des IgA polymériques (1,000,000—320,000 et 320,000 daltons).
Ainsi, en conditions d'élution acide, 64% du total des IgA éluées sont
sous forme polymdrique. La fixation d'IgA polymeriques sur le
composant secrCtoire a Ctd ddmontrCe dans quatre des huit Cluats
testes. Le point isoClectrique (p1) des IgA CluCes vane de 4.5 a 5.6
correspondant a une restriction du p1 des IgA mCsangiales comparées
aux IgA du serum dont le p1 vane de 4.5 a 6.8. Cette étude montre que
Ia nature multimerique de l'IgA, Ia formation de complexes, ou d'ag-
gregats d'IgA et Ia charge anionique de l'lgA dluée du mesangium sont
probablement impliquCes dans Ia deposition mCsangiale au cours de Ia
nephropathie a IgA.
IgA nephropathy is a form of glomerulonephritis (GN) char-
acterized by mesangial granular deposits of IgA in patients
presenting macroscopic or microscopic hematuria [1—3]. This
disease is most common in young adults, predominantly in
males [21. It is the most frequent type of primary GN in several
countries, with a prevalence ranging from 20 to 25% in southern
Europe and Australia [4—6], up to 40% in Japan [7, 8]. In the
long term, IgA nephropathy seems to progress to end-stage
failure in about 25% of the patients, twenty years after the
apparent onset [9].
The origin of mesangial IgA and the mechanism(s) responsi-
ble for its deposition remain unknown. The recurrence of
deposited IgA in grafted kidneys [101, the elevation of serum
IgA levels in about 30 to 50% of the cases [4, 5], a decrease of
IgA specific suppressor T cell activity [1 1—1 31, and an increase
of IgA specific helper T a cells [13, 141 suggest that the host
immune response plays a role in the mechanism of the disease.
Increase of polymeric forms of serum IgA, in these patients, has
been reported [15—17], but could not be confirmed [18, 19]. No
secretory component (SC) could be demonstrated along with
the IgA deposited in the kidney by immunofluorescence studies
[20]. However, the presence of polymeric IgA in the mesangium
has been suggested by the in vitro fixation of the SC, although
1gM could bind it also [21]. Dimeric IgA was demonstrated in
eluates of open renal biopsy specimens from patients with IgA
nephropathy [22].
Experimental models were first to suggest that only poly-
meric IgA or IgA immune complexes can be deposited in the
mesangium [23, 24]. Recently, in experimental IgA nephrop-
athy induced in mice after oral immunization, antigens, J chain,
and IgA were detected in the mesangial area, showing that IgA
is polymeric and probably derived from the secretory sites [25].
The purpose of this study was to analyze the physicochemical
characteristics of mesangial IgA in primary IgA nephropathy.
Since these properties can only be evaluated on soluble mate-
rial, we first developed a micro-elution technique, which,
coupled to a sensitive IgA-radioimmunoassay (RIA), allowed us
to study the eluted material from routine percutaneous kidney
biopsies.
Methods
Patients
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Routine percutaneous renal biopsy specimens were obtained
from 20 patients (13 males and seven females; mean age 31 15
yrs, range, 14 to 69 yrs) with primary IgA nephropathy. The
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diagnosis was made based upon clinical, immunofluorescence,
and light microscopic findings. The patients had recurrent upper
respiratory tract infections (9/20), macroscopic hematuria
(8/20), hypertension (4/20), nephrotic syndrome (1/20), protein-
uria < 3 g124 hr (17/20). Ten patients were asymptomatic, and
glomerulonephritis was discovered by routine analysis for pro-
teinuria or hematuria. Seventeen of the 20 patients had normal
renal function, and three of the 20 had moderate renal failure.
None of them had clinical or biochemical evidence of systemic
lupus erythematosus, liver disease, Henoch-Schonlein syn-
drome, or other systemic diseases.
Analyses
Light microscopic and immunofluorescence studies
Renal tissue was prepared for light microscopic studies as
described previously [10]. For direct immunofluorescence stud-
ies, the specimens were frozen in isopentane cooled by liquid
nitrogen and 3 pm sections were cut using a Slee cryostat. In
each case, the following fluorescein isothiocyanate conjugated
antisera were used on unfixed cryostat sections: anti-human y,
a, p, C3, C4, Clq, fibrinogen, and albumin (Hyland Laborato-
ries, Costa Mesa, California, USA, or Behringwerke A.G.,
Marburg an der Lahn, West Germany). The monospecificity of
each antiserum was tested by immunodiffusion. Patients with-
out tubular casts containing IgA, without IgA plasma cells in
the interstitium, with few sclerotic glomeruli, and with strongly
fluorescent IgA mesangial deposits were chosen deliberately.
Four renal biopsy specimens from patients presenting
hematuria and/or proteinuria, but in whom the kidneys were
found to be normal by light and immunofluorescence micro-
scopic analyses, were used as controls.
Micro-elution procedures
The elutions were performed on 20 renal biopsy specimens
from patients with IgA nephropathy and on four normal renal
biopsy specimens. Serial sections 3 .m thick of the specimens
were prepared with a cryostat. The number of glomerular
sections was determined by light microscopy every ten sec-
tions. Glomerular sections that ranged from 505 to 2300, with a
mean SD = 1,287 498, were used. The serial sections were
incubated at 1 ml of phosphate buffered saline (PBS) in 1.5 cc
microfuge tubes (Beckman Instruments, Fullerton, California,
USA) for 5 mm with gentle shaking at room temperature and
centrifuged for 30 mm (4,000g) at 4°C. This washing procedure
was repeated 3 times and the pellet was resuspended and
incubated for 4 hrs at 37°C in 200 l of 0.02 Mcitrate buffer, pH
3.2 [26]. When indicated, I g/ml aprotinin (Sigma Chemical
Co, St. Louis, Missouri, USA) and 1 mrvi phenylmethylsullon-
ylfluoride (Sigma) were added at 0 and 2 hrs, to prevent
proteolysis during the elution. After elution, the renal tissues
were centrifuged (4,000g for 30 mm) and the eluates were
neutralized with 40l of I M Na2HPO4 and stored at —80°C. The
total protein concentration in the eluates was measured using
the Bradford method [27] (BlO-RAD Chemical Division, Rich-
mond, California, USA).
Purification of IgA
Briefly, highly purified IgA was obtained from normal human
sera (NHS) by euglobulin precipitation (2.5 ifiMEDTA, 5 mM
phosphate buffer, pH 5.9) and DEAE ion-exchange chromatog-
raphy (Whatman, London, England), followed by passage
through a Sephadex G 200 column equilibrated with PBS. The
pooled IgA fractions passed over Sepharose 4B-anti-human
IgG. The purified IgA contained over 95% IgA as assessed by
immunodiffusion, immunoelectrophoresis using anti-whole hu-
man serum antiserum (Hyland) and by SDS-polyacrylamide gel
electrophoresis using 5.6% acrylamide gels. The IgG content
was less than 0.1% measured by immunonephelometry
(Hyland).
Chromatographic analysis
Eleven eluates were subjected to high pressure liquid chro-
matography (HPLC) on columns, 7.5 mm ID x 30 cm, of
Spherogel TSK G 4,000 SW dp 10 s (Altex Scientific Inc.,
Berkeley, California, USA; with 5,000 to 1,000,000 dalton
fractionation range). 250 p1 were applied to the HPLC column
with a flow rate of 0.1 mllmin, and 250 p1 fractions were
collected in 1% ovalbumin-PBS coated tubes, The column was
standardized with molecular weight markers (acid treated under
the same conditions as the eluates): free Na'25!, IgA, monoclo-
nal dimeric IgA, and dextran blue (2 X 106 daltons). Six eluates
were analyzed in 0. 1M phosphate buffer, pH 6.8 containing 0.1
M NaCI; three eluates were mixed with 2Opi of IM citric acid,
chromatographed in 0.02 M citrate buffer, pH 3.5 containing 0.1
M NaCl and neutralized after HPLC with 30p1 of 1M Na2HPO4;
and two eluates (Nos. 7 and 8) were divided into two samples
and analyzed using both buffers. Monoclonal dimeric IgA was
provided by Dr. S. Iscaki (Inst. Pasteur, Paris, France) [28].
Isoeleciric focusing (JEF)
Five eluates were analyzed on agarose gels (1.5 mm) contain-
ing 0.8% agarose (agarose EF, LKB Instruments, Inc.,
Gaithersburg, Maryland, USA), 10% sorbitol and 2.5%
ampholyte (ampholine 3.5 to 9.5, LKB). The mixture was
dissolved in double distilled water and poured onto a gelbond
covered glass plate (LKB) and kept overnight at 4°C. All
focusing was performed on an Ultraphor apparatus (LKB)
cooled by a thermostatically regulated water bath set at 10°C.
The anolyte was 0.5 M acetic acid and the catholyte 0.5 M
sodium hydroxide. A 1401.d aliquot from each sample, previ-
ously dissociated with 10 p1 of 1 Mcitric acid, was applied in the
middle of the agarose gel. Purified IgA and NHS (acid treated
under the same conditions as the eluates) were analyzed by IEF
as controls. The proteins were then focused with a constant
power of 10W for 1.5 hrs. The gel was cut into 0.5 cm x 1 cm
gel slices [291 and incubated overnight at 4°C in 0.2 ml NaCI-
EDTA-Tris buffer (150mM NaCI, 5 m EDTA, 50 mt Tris and
0.02% sodium azide, pH 7.0) containing 1% ovalbumin and
0.05% Nonidet P-40 (NP-40, Shell Chemical Co., London,
England) (NP4O-OVA-NET buffer). Direct pH measurements
were made with control slices incubated in water. Anodic and
cathodic fractions were neutralized to pH 7.0 with I M Tris or
1 M HCI, respectively.
IgA radioimmunoassay
IgA was detected in the HPLC and IEF fractions by RIA
using rabbit anti-human a chain antibody (Dakopatts,
Copenhagen, Denmark) and normal polyclonal IgA, purified as
described above, was radioiodinated with Na'251 (Amersham,
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Buckinghamshire, England) for each assay, by the chloramine
T method [30]. The specific activity was 8 x iO cpmlp.g.
Formalin-fixed staphylococcus aureus (staph A) (Bethesda Re-
search Laboratories, Inc., Gaithersburg, Maryland, USA),
pretreated in 10% f3-mercaptoethanol and 3% SDS at 95°C for
30 mm, and washed in PBS and in NP4O-OVA-NET buffer, was
used to precipitate anti-IgA antibodies [31]. The inhibition of
'251-IgA binding to anti-IgA antibodies by the unknown sample
was determined after precipitation with staph A and the sensi-
tivity of this IgA-RIA was 0.02 ng, (50% inhibition ranged
between 0.07 and 0.12 ng). The antibody was considered
monospecific for the determination of IgA levels because IgG
and 1gM failed to inhibit the '251-IgA binding at concentrations
2 x l0 times greater than the sensitivity.
Secretory component binding assay
The binding of purified human colostrum SC was assessed in
the HPLC fractions corresponding to the IgA peaks. The SC
was 25I-1abeled by the Bolton and Hunter reagent (Amersham)
with a specific activity of I x 106 cpmI.&g. HPLC fractions were
incubated sequentially with '251-SC and anti-a chain antibody
for 1 hr at 37°C. The binding of SC to IgA was detected by the
precipitation of the '251-SC-IgA-anti-a chain complexes by
staph A in NP4O-OVA-NET buffer. The results were calculated
according to the following formula:
Index of SC binding = experimental bound cpm — background cpm
buffer bound cpm — backgroundcpm
The assay was considered positive when the index was 2
(0.1 ng of human monoclonal dimeric IgA corresponds to a SC
binding index of 2.1). Purified SC was provided by Dr. S. Iscaki
(Inst. Pasteur, Paris, France) [28].
Results
Pathological findings
In immunofluorescence studies, IgA deposits were found
predominantly in the mesangial area and were brightly stained.
Eleven out of the 20 patients had small amounts of 1gM, while
16 of them had small amounts of IgG in association with the IgA
deposits. C3 was present in the mesangium like IgA, but was
less intensely stained.
Light microscopic studies revealed mesangial enlargement in
all patients. Seven out of the 20 cases had slight focal mesangial
hypercellularity. Four of the patients presented diffuse
moderate mesangial proliferation. Nine cases exhibited seg-
mental lesions characterized by either sclerosis or epithelial
proliferation.
Protein and IgA contents of the eluates
The total amounts of eluted proteins were comparable in four
patients and in four normal kidneys (4.3 0.93 g from 1386
431 glomerular sections and 4.7 1.2 tg from 1590 401
glomerular sections, respectively). IgA amounts (mean SD) in
eleven eluates prepared from IgA nephropathy biopsy speci-
mens were 15 10 ng (ranging from 0.7 to 28 ng), equivalent to
about 0.4% of the total eluted proteins. In contrast, no IgA was
detected in four normal renal eluates, thus demonstrating that
the washes prior to elution removed serum proteins effectively.
The amounts of eluted IgA did not correlate with the size and
Table 1. Molecular weight distribution of mesangial IgA after high
pressure liquid chromatography at pH 6.8 and/or pH 3.5
x
MW,
10' daltons
% of eluted IgA under
Neutral Acidic pa
<160 27± 18 22±12 NS
160 18± 12 10± 7 NS
320 18 15 37 12 < 0.05
320 to 1000 5 6 27 23 <0.05
1000 29 16 5 7 <0.01
a Significant differences (Student's t test) were found between dif-
ferent molecular weights under both conditions.
intensity of the deposits analyzed by immunofluorescence in a
double blind study, according to linear regression analysis (r =
0.45, NS).
Molecular weight analysis and SC binding of eluted IgA
Eleven eluates were used to separate IgA according to
molecular weight by high pressure liquid chromatography.
Fractions from eight of these eluates were then divided into two
samples: one for IgA detection by IgA-RIA and the other for the
SC binding assay. Since the three remaining eluates contained
insufficient amounts of IgA for both assays, only the IgA-RIA
was performed. The percentages of IgA molecular forms were
determined by profile integration after HPLC. Table 1 shows
the results obtained with eight eluates analyzed under non-
dissociating conditions (pH 6.8) and five eluates subjected to
acidic chromatography, at pH 3.5. Comparison of the molecular
weights of eluted IgA after pH 6.8 and pH 3.5 HPLC column
shows a decrease of the excluded IgA peak (' 1,000,000
daltons) and an increase of 1,000,000—320,000 and 320,000
dalton IgA peaks (64% of total eluted IgA) after acidic chroma-
tography, with statistically significant differences according to
the Student's t test (P < 0.01 and P < 0.05, respectively). The
IgA monomer peak (160,000 daltons) represented 10 to 20% of
the total IgA content in both analyses, but showed no significant
differences. For two eluates (Nos. 7 and 8), the amounts of
eluted IgA were sufficient to be analyzed under both buffer
conditions (Fig. 1). Elution profiles at acid pH differ from
non-dissociating conditions, mainly by the decrease of the large
molecular weight ( 1,000,000 daltons) IgA peaks and the
predominance of the dimeric IgA forms. The low molecular
weight compounds, smaller than 160,000 daltons, were found in
both cases, as well as the presence of protease inhibitors in six
patients analyzed. There were no significant statistical differ-
ences between elutions without (elutions 1 to 5) or with (elu-
tions 6 to 11) protease inhibitors (mean, 27 17 or 22 12%,
respectively). The affinity of eight eluates for purified SC was
analyzed after HPLC. In four eluates, SC binding IgA were
found in polymeric forms. Patient eight's eluate was analyzed
under both conditions, and the dimenc IgA fractions (320,000
daltons) bound the SC only after dissociating chromatography
(Fig. 1). Neither monomers nor large molecular weight IgA
bound the SC. Fifty percent of the eluates did not bind any SC
under the same conditions.
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Fig. 2. Charge distribution of mesangial IgA analyzed br isoelectric
focusing on agarose gels. Focusings were performed in the pH range
3.5 to 9.5, described in Methods. The gel was sliced and proteins were
eluted. The IgA was detected in the eluates by an IgA-RIA; five patients
(—); highly purified serum IgA (----); and IgA detected in NHS (-S-). The
hatched area () represents the normal isoelectric range of serum IgA.
Fraction number
Fig. 1. A HPLCelution profiles of mesangial IgA (Patient 7), using two
different pH buffers (pH 6.8 (—) andpH 3.5 ( )). IgA was detected in
the fractions by an IgA-RIA. SC binding was determined in the IgA
peaks, described in Methods. Positive binding is shown at both elution
conditions (pH 6.8 () and pH 3.5 (0)). B HPLC elution profiles of
mesangial IgA (Patient 8), as described above.
Charge characterization of mesangial IgA
The charge of eluted IgA was analyzed for five patients by
isoelectric focusing on agarose. After migration, the gel slice
eluates were tested for their IgA contents by IgA-RIA. Figure 2
shows the isoelectric points (p1) of eluted IgA for all patients
and normal serum IgA (purified serum IgA and NHS). The p1 of
eluted IgA ranged from 4.5 to 5.6, contrasting with the more
heterogeneous p1 of purified serum IgA and IgA detected in
NHS treated under the same conditions as the eluates (4.7 to 6.8
and 4.5 to 6.6, respectively). A small basic IgA peak was
observed for all eluates studied, with p1 between 7.8 and 8.0,
varying from 13 to 35% of the IgA peaks, determined by profile
integration.
Discussion
We have developed a micro-elution technique, which allows
the recovery of nanogram quantities of mesangial IgA, deter-
mined by a sensitive IgA-RIA, using routine percutaneous renal
biopsy specimens obtained from IgA nephropathy patients.
Cases presenting only mesangial IgA deposits were chosen in
order to elucidate the factors involved in the mesangial IgA
deposition. The amount of eluted IgA was equivalent to 0.4% of
the total proteins present in the eluates, which were primarily
kidney tissue proteins removed by the acidic treatment.
The predominant molecular weight of the mesangial IgA was
polymeric (' 320,000 daltons). Under neutral chromatography,
29% of the eluted IgA was high molecular weight IgA com-
plexes (' 1,000,000 daltons), as described previously [32]. In
contrast, under acidic conditions these IgA complexes were
mainly dissociated into dimeric fractions (320,000 daltons),
corresponding to 37% and constituting the major molecular
form of the eluted IgA. This is consistent with the results of
Tomino et al [22], who found mainly dimeric IgA in eluates of
open surgical biopsy specimens.
In an attempt to prevent possible proteolysis by low pH-
active tissue peptidases, we examined six elutions in the
presence of protease inhibitors. There were no significant
differences between the elutions performed with or without
these inhibitors. Indeed, IgA cleavage did not occur during the
elution process, since the addition of intact '251-IgA at the time
of elution, in the presence or absence of protease inhibitors, did
not lead to the degradation of the labeled IgA. Thus, the small
IgA peptides found in this study (50,000 to 5,000 daltons)
probably result from IgA degradation either in vivo by mesan-
gial [33, 34] or circulating cell enzymes, or during the time
between the biopsy and freezing.
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Secretory component binding capacity was assessed in the
HPLC fractions containing IgA. Four of the eight eluates tested
contained polymeric IgA with SC binding activity. It is possible
that the four negative eluates contained mainly polymeric IgA
which lacked the J chain [35]. This form is known to have no
affinity for SC at physiological ionic strength. On the other
hand, the SC binding assay may not be sensitive enough to
detect minute quantities of polymeric IgA (< 0.1 ng) in the
HPLC fractions. After chromatography, it was shown that only
polymeric but not monomeric IgA bound SC. The larger IgA
peak eluted in the void volume did not consistently bind SC,
possibly because of inhibition by 1gM often present in the
glomeruli, or as a result of a particular arrangement of the high
molecular weight IgA complex restricting SC access.
These results suggest that mesangial IgA is composed mainly
of polymeric and dimeric IgA, representing 64% of the total
eluted IgA, with affinity for SC. Furthermore, this percentage is
probably underestimated, since the RIA was standardized using
monomeric IgA and did not take the IgA size into account [36].
However, it is not known from this study whether IgA antibody
activity (anti-antigens or anti-idiotypes) is involved in the
formation of complexes. This could be suggested indirectly by
the dissociation of the eluted high molecular weight mesangial
complexes under acidic conditions, although they may also be
IgA aggregates.
The isoelectrofocusing study of the mesangial IgA revealed a
similar pattern for the five biopsy specimens studied. The eluted
IgA was predominantly anionic, with a p1 ranging from 4.5 to
5.6. On the other hand, highly purified IgA or IgA present in
normal serum, treated under the same acidic conditions as the
eluates, showed a broad range of p1(4.5 to 6.8). In each eluate,
a small amount of highly "basic IgA" (p1 7.8 to 8.0) was also
found. Whether this represents abnormal IgA, IgA fragments,
or IgA covalently bound to a basic compound cannot be
determined from this study.
The restricted p1 of eluted IgA suggests that electrostatic
binding may play a role in mesangial IgA deposition. In the
majority of cases, no mesangial IgA deposits remained after
elution, as assessed by immunofluorescence, thus excluding a
selection of an IgA subpopulation of low p1 by the acidic
treatment.
The predominant anionic nature of the mesangial IgA in IgA
nephropathy may be due to a particular carbohydrate compo-
sition or to a high content of acidic amino acids in the variable
region.
Our findings are consistent with numerous experimental
models that show molecular size and charge-dependent glomer-
ular deposition. The mesangial matrix has been shown to entrap
large circulating soluble macromolecules, such as aggregated
human IgG or large preformed immune complexes [37—40]. The
negative charge of the elated IgA from patients with idiopathic
IgA nephropathy that we observed is reminiscent of experimen-
tal models in which anionic antibodies, antigens, or immune
complexes were deposited in the mesangium [41—43].
In conclusion, although the origin of the deposited IgA and its
antibody activity in patients with primary IgA nephropathy are
still unclear, this study suggests three conditions that may favor
mesangial IgA deposition: I) the multimeric nature of IgA; 2)
circulating or in situ IgA complex formation; and 3) the anionic
charge of IgA.
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